India Drug-Pricing Authority To Give Pharmas Incentives To Improve Products (India)
This article was originally published in PharmAsia News
Executive Summary
India's National Pharmaceutical Pricing Authority plans a new system that would require drug makers to undergo more scrutiny on whether new ingredients and packaging materials improve the quality of their drug. The changes are intended to give pharmas incentives to make those changes because they then would be able to charge a higher price for their product if the changes improve quality. Drug makers have said the price controls placed on them in India kept the companies from making changes to extend the shelf life of their drugs and enhance their qualities. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.